Regenerative Medical Technology RMTG
OTC RMTG
$0.03 +0.00 (+0.00%)
At close: Nov 9, 2026 · 4:00 PM EST

Regenerative Medical Technology (RMTG) EV to CFO (2024 - 2026)

Updated

Regenerative Medical Technology's (RMTG) EV to CFO stood at -2.37 in Q2 2026, compared with -9.99 a year earlier.

Analysis

Regenerative Medical Technology (RMTG) EV to CFO (2024 - 2026) Analysis & Trends

On a TTM basis, Regenerative Medical Technology's EV to CFO came in at -14.30 as of Jun 30, 2026; for FY2024, it was -0.93.

  • The Q2 2026 figure is the highest quarterly EV to CFO since Q1 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Regenerative Medical Technology 412,169.03 -4.11 Mn 2.58 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -2.37
Jun 30, 2025 -9.99
Mar 31, 2025 -1.06
Dec 31, 2024 -0.93
Sep 30, 2024 -1.04
Jun 30, 2024 -0.66
API Access

Regenerative Medical Technology EV to CFO API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-cfo&ticker=RMTG&period=max&api_key=YOUR_API_KEY